OHB Faces the Unfiltered Market as J.P. Morgan’s Safety Net Prepares to Exit

J.P. Morgan's artificial support for OHB shares expires July 24, leaving the stock to trade below its €300 placement price amid heavy dilution and 80% volatility.

The clock is ticking on OHB’s artificial market support. Come Friday, the one-month stabilization period that followed the company’s June capital increase officially expires, leaving the German space and defense contractor’s shares to fend for themselves against raw supply and demand. For a stock that has already shed more than a third of its value since the capital raise, the transition promises to be anything but smooth.

The Scale of the Intervention

J.P. Morgan SE, acting as stabilization coordinator, disclosed on July 20 that it purchased 2,930,480 newly issued OHB shares on Xetra between July 13 and July 17. The buying spree was part of a broader stabilization effort that began on June 24 and is scheduled to conclude on July 24. Such interventions are standard practice after large capital market transactions, designed to cushion short-term price swings as the market absorbs a flood of new equity.

The numbers reveal just how heavy the intervention was. OHB placed roughly 1.7 million new shares at €300 apiece in late June, raising gross proceeds of around €484 million across two tranches. The first tranche alone carried an offer volume of €900 million. Yet retail shareholders showed almost no appetite for the deal: only 7,635 new shares were subscribed through rights offerings, meaning the vast majority of the issue went unclaimed by existing investors and was left to institutional buyers and the stabilizing banks.

A Stock Under Pressure

The market’s verdict has been harsh. The shares closed at €250.00 in the primary article’s data, while the secondary source reports a slightly different €249.50 — a gap that reflects intraday volatility. Either way, the stock is trading well below the €300 placement price. Over the past 30 days, the decline stands at roughly 34% to 36%, depending on the measurement point. The annualized 30-day volatility of 80.22% underscores just how nervous the trading has become.

The technical picture offers little comfort. The 200-day moving average sits at €239.49, leaving the current price just 4.39% above that critical support level. A decisive break below that line could trigger automated selling programs, compounding the downward pressure. The relative strength index hovers around 35.5 — deep in oversold territory, which at least suggests that much of the selling may already be priced in.

The Record Book That Can’t Stop the Bleeding

Operationally, OHB has plenty to boast about. The company reported a record order backlog of approximately €3.35 billion at the end of the first quarter of 2026, fueled by surging demand for military satellite infrastructure. High-profile visits from German federal politicians have reinforced the company’s strategic importance for national sovereignty in space. Major projects like the IRIS² satellite constellation and the RAMSES mission underpin the long-term growth narrative.

But the market is currently fixated on dilution, not backlog. The capital increase swelled the number of freely tradable shares, and the stabilization purchases were precisely what filled the demand gap. Once those purchases stop, the question is whether genuine buyers will step in. The current market capitalization of €4.71 billion implies that investors are betting on smooth execution of those big-ticket projects — a bet that upcoming interim reports will need to validate.

What Comes Next

The immediate risk is a demand vacuum. With the stabilization consortium stepping aside, the stock will face the full force of order flow without a backstop. Institutional investors may continue adjusting their positions, and the volatile space sector — still digesting the June IPO of SpaceX — adds another layer of uncertainty.

The 200-day moving average at €239.49 is the line in the sand. Hold it, and the oversold RSI could fuel a technical bounce, potentially aiming for the 50-day average at €375.42 — though that would require a 33% rally from current levels. Lose it, and the path could open toward the 52-week low of €64.00, however remote that scenario may seem.

For now, the next trading week will serve as the first real test of OHB’s standalone market appeal. The stabilization period ends Friday. The real trading begins Monday.